Dr . Reddy Enters Trade Generics , Child Nutrition , Expanding Its Indian Footprint
India's largest pharmaceutical company, Dr. Reddy, has announced it is entering the trade generics business in India. The company has launched a new business unit, which will focus on acute segment products, child nutrition and child breasts.
Source: ibtimes.co.inPublished on 2023-07-20
Related news
- 23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results
- Is oil dead ? Black gold loses its sparkle
- Hotel Green Marketing Effects on Your Business Performances
- ESAs call for development of securitised asset disclosure standards | News
- Redefining Authenticity When Youre Faced With a Brand Identity Crisis
- Davos updates | VW : Supply chain woes ease ; orders backed up
- A Hydrogen - Led Net - Zero Future , Seagrass - Based Carbon Credits , And A Chat With Tetra Pak Lars Holmquist
- Climate change litigation increasing globally since 2015 , report finds
- Bureau Veritas Hails Government Cop26 Sustainable Financing Policies As Key In Shaping A World Of Trust
- Fashioning a change | The Navhind Times
- Semtech Unveils New Brand Reflecting Company Vision to Enable a Smarter , More Connected and Sustainable Planet – Consumer Electronics Net
- Anika Completes Enrollment in Hyalofast® U . S . Pivotal Phase III Study Achieving Key Milestone
- Sector In Focus : Malta Gears Up For Sustainable Finance - Finance and Banking
- ESG 101 : What Is ESG , and Does It Matter ?
- Net zero strategy : The key policies in the Government ambitious plan to be more sustainable